Synjardy 5/850 Mg F/C Tabs 60'S
Synjardy 5/850 Mg F/C Tabs 60'SSold out

Synjardy 5/850 Mg F/C Tabs 60'S

14.68 KWD

01

Shop & Discover More

product image
Boehringer Ingelheim

Synjardy 5/1000 mg F/C Tabs 60'S

15.18Kwd
product image
Boehringer Ingelheim

Pradaxa 110Mg Caps 30'S 0295

13.63Kwd
product image
Boehringer Ingelheim

Mobic Tablets 7.5Mg 10 Tab

0.88Kwd
Dorofen 40 Capsule
Pharmacy Plus®

Dorofen 40 Capsule

5.72Kwd

Synjardy 5 mg/850 mg Film-Coated Tablets (60's)

✅ Active Ingredients:

✅ Therapeutic Class:

✅ Indication:

✅ Mechanism of Action:

  1. Empagliflozin (SGLT2 inhibitor):

    • Inhibits sodium-glucose cotransporter-2 (SGLT2) in the kidneys.
    • Increases urinary glucose excretion, leading to lower blood sugar levels.
    • Reduces glucose toxicity and insulin resistance.

  2. Metformin (Biguanide):

    • Reduces hepatic glucose production.
    • Improves insulin sensitivity in peripheral tissues.
    • Slows down intestinal glucose absorption.

✅ Dosage & Administration:

✅ Contraindications:

✅ Warnings & Precautions:

✅ Common Side Effects:

✅ Storage Conditions:

✅ Manufacturer:

✅ Country of Manufacture: